Butensky & Cohen Financial Security’s Pfizer PFE Stock Holding History

Butensky & Cohen Financial Security’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-395	Closed	-$13K	–	106
2017 Q2	$13K	Hold	395	–	–	0.01%	98
2017 Q1	$13K	Hold	395	–	–	0.01%	97
2016 Q4	$12K	Hold	395	–	–	0.01%	93
2016 Q3	$13K	Hold	395	–	–	0.01%	88
2016 Q2	$13K	Hold	395	–	–	0.01%	84
2016 Q1	$11K	Hold	395	–	–	0.01%	95
2015 Q4	$12K	Hold	395	–	–	0.01%	101
2015 Q3	$12K	Hold	395	–	–	0.01%	97
2015 Q2	$13K	Buy	395 +174	+79%	+$5.67K	0.01%	96
2015 Q1	$7K	Hold	221	–	–	0.01%	96
2014 Q4	$7K	Buy	+221	New	+$6.34K	0.01%	97

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Butensky & Cohen Financial Security's PFE Position: Q3 2017 in Review

Butensky & Cohen Financial Security sold out of Pfizer (PFE) in Q3 2017, closing a stake of 395 shares — an estimated $13K sold.

Butensky & Cohen Financial Security first reported a position in PFE in Q4 2014 and held it in 11 quarters. The position peaked at $13K in Q2 2017. 2,042 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

Butensky & Cohen Financial Security reported no remaining Pfizer position as of Q3 2017 after selling out during the quarter.
Butensky & Cohen Financial Security sold 395 Pfizer shares in Q3 2017, an estimated $13K.
Butensky & Cohen Financial Security first reported a position in Pfizer in Q4 2014 and held it in 11 quarters.
Butensky & Cohen Financial Security's Pfizer position peaked at $13K in Q2 2017.
2,042 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Butensky & Cohen Financial Security's 13F filing for Q3 2017, filed 20 Oct 2017.